drugset / Trial / NCT02936154
Study for MR Formulation of PF-06650833 in Healthy Adult Japanese Subjects
RandomizedParallel-groupTriple-blindBasic science
Summary
The purpose of this study is to evaluate the tolerability, safety and pharmacokinetics of PF-06650833 orally administered as modified release tablets in healthy Japanese subjects.
Timeline
- Start
- 2016-08
- Primary completion
- 2016-10
- Completion
- 2016-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZIMLOVISERTIB | Small molecule | 300 mg | Oral |
Indications
No indication recorded.